Collecting data on chronic viral hepatitis patients
Real World Study of Chronic Viral Hepatitis
This study is trying to collect information from people with chronic viral hepatitis to better understand their long-term health and improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Huashan Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT04025944 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather and analyze clinical data from patients suffering from chronic viral hepatitis to understand their long-term outcomes better. By utilizing real-world evidence, the study seeks to identify the characteristics of these patients and optimize treatment strategies accordingly. Chronic viral hepatitis can lead to severe liver complications, and this research addresses the gap in high-quality evidence regarding its management. The study will involve patients who have shown persistent viral infection for over six months.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with a confirmed diagnosis of chronic viral hepatitis, evidenced by persistent virus infection for more than six months.
Not a fit: Patients with serious psychiatric conditions or significant organ diseases, as well as those with malignant tumors, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options and better management strategies for patients with chronic viral hepatitis.
How similar studies have performed: Other studies utilizing real-world data have shown promise in improving understanding and management of chronic conditions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Informed consent of patients. 2. Evidence of persistent virus infection for greater than six months \[hepatitis C virus(HCV) RNA positive, hepatitis B surface antigen(HBsAg) or hepatitis B virus(HBV) DNA positive\] Exclusion Criteria: 1. Serious psychiatric history, especially depression. * Severe mental illness is defined as major depression or psychosis, suicide attempts, hospitalization due to mental illness or a period of disability due to mental illness. 2. Patients with serious diseases of heart, lung, kidney, brain, blood and other important organs. 3. Patients with malignant tumors (excluding those cured).
Where this trial is running
Shanghai, Shanghai Municipality
- Huashan Hospital — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Study coordinator: Yiqi Yu, Doctor
- Email: yyq19890619@126.com
- Phone: 13601637563
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.